Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics;
应用:
Tedizolid phosphate-d3 is labelled Tedizolid Phosphate (T013755). It is approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Tedizolid phosphate is a prodrug that is rapidly converted to the active compound tedizolid, which has activity against a wide range of gram-positive pathogens, including methicillin-resistant Staphylococcus aureus.